Annotation Detail

Information
Associated Genes
MAGEH1
Associated Variants
MAGEH1 EXPRESSION
MAGEH1 EXPRESSION
Associated Disease
bile duct adenocarcinoma
Source Database
CIViC Evidence
Description
10 biliary tract carcinoma cell lines were sorted based on their gemcitabine sensitivity. MAGEH1 protein expression was negatively correlated with sensitivity. In a clinical validation cohort, MAGEH protein expression was found in 4/4 "non-effective" cases and 2/5 effective cases based on RECIST criteria after gemcitabine treatment.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/950
Gene URL
https://civic.genome.wustl.edu/links/genes/11261
Variant URL
https://civic.genome.wustl.edu/links/variants/406
Rating
2
Evidence Type
Predictive
Disease
Bile Duct Adenocarcinoma
Evidence Direction
Supports
Drug
Gemcitabine
Evidence Level
D
Clinical Significance
Resistance
Pubmed
20088962
Drugs
Drug NameSensitivitySupported
GemcitabineResitance or Non-Reponsetrue